References
- Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005;115:1275–1280
- Desir GV. Renalase is a novel renal hormone that regulates cardiovascular function. J Am Soc Hypertens. 2007;1:99–103
- Desir GV. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens. 2008;17:181–185
- Go AS, Lo JC. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006;15:296–302
- Luft FC. Renalase, a catecholamine-metabolizing hormone from the kidney. Cell Metab. 2005;1:358–360
- Desir GV, Tang L, Wang P, et al. Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc. 2012;1:e002634
- Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011;95:875–892
- Straznicky NE, Grima MT, Sari CI, et al. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes. 2012;61:2506–2516
- K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1–S266
- Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–1495
- Pansuria M, Xi H, Li L, et al. Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci (Schol Ed). 2012;4:916–931
- Desir G. Novel insights into the physiology of renalase and its role in hypertension and heart disease. Pediatr Nephrol. 2012;27:719–725
- Zhao Q, Fan Z, He J, et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med (Berl). 2007;85:877–885
- Farzaneh-Far R, Desir GV, Na B, et al. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One. 2010;5:e13496
- Stec A, Semczuk A, Furmaga J, et al. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant. 2012;27:4162–4166
- Buraczynska M, Zukowski P, Buraczynska K, et al. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med. 2011;13:321–327
- DE Boer MP, Meijer RI, Wijnstok NJ, et al. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation. 2012;19:5–18
- Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374–381
- Desir GV. Role of renalase in the regulation of blood pressure and the renal dopamine system. Curr Opin Nephrol Hypertens. 2011;20:31–36
- Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int. 2009;76:366–370
- Xu J, Desir GV. Renalase, a new renal hormone: its role in health and disease. Curr Opin Nephrol Hypertens. 2007;16:373–378
- Wang J, Qi S, Cheng W, et al. Identification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep. 2008;35:613–620
- Ghosh SS, Gehr TWB, Sica DA, et al. Renalase regulates blood pressure in salt sensitive Dahl rats. J Am Soc Nephrol. 2006;17:208 (Abstract)
- Ghosh SS, Krieg RJ, Sica DA, et al. Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatr Nephrol. 2009;24:367–377
- Baraka A, El Ghotny S. Cardioprotective effect of renalase in 5/6 nephrectomized rats. J Cardiovasc Pharmacol Ther. 2012;17(4):412–416
- Gu R, Lu W, Xie J, et al. Renalase deficiency in heart failure model of rats – a potential mechanism underlying circulating norepinephrine accumulation. PLoS One. 2011;6:e14633
- Wu Y, Xu J, Velazquez H, et al. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011;79:853–860
- Weinman EJ, Biswas R, Steplock D, et al. Increased renal dopamine and acute renal adaptation to a high-phosphate diet. Am J Physiol Renal Physiol. 2011;300:F1123–F1129
- Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol. 2010;7:431–441
- Wang F, Zhao Q, Xing T, et al. Renalase-specific polyclonal antibody and its application in the detection of renalase's expression. Hybridoma (Larchmt). 2012;31:378–381
- Mori T, Ogawa S, Cowely AW Jr, et al. Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes. Clin Exp Pharmacol Physiol. 2012;39:125–131
- Grassi G, Bertoli S, Seravalle G. Sympathetic nervous system: role in hypertension and in chronic kidney disease. Curr Opin Nephrol Hypertens. 2012;21:46–51
- Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011;95:875–892
- Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation in hypertension. Curr Opin Nephrol Hypertens. 2011;20:647–653
- Sobotka PA, Mahfoud F, Schlaich MP, et al. Sympatho-renal axis in chronic disease. Clin Res Cardiol. 2011;100:1049–1057
- Maric C, Hall JE. Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol. 2011;170:28–35
- Przybylowski P, Malyszko J, Kozlowska S, et al. Serum renalase depends on kidney function but not on blood pressure in heart transplant recipients. Transplant Proc. 2011;43:3888–3891
- Wang F, Xing T, Li J, et al. Renalase's expression and distribution in renal tissue and cells. PLoS One. 2012;7:e46442
- Desir GV, Peixoto AJ. Renalase in hypertension and kidney disease. Nephrol Dial Transplant. 2013 Oct 18. [Epub ahead of print]